For example, some individuals taking GLP-1s report fatigue, muscle loss, and constipation
GLP1- injections offer cardio protective effects and help reduce the risk of cardiovascular disease (CVD) in adults with type 2 diabetes (T2DM) or high atherosclerotic cardiovascular disease (ASCVD) risk
When to split You need a split injection when your calculated volume exceeds 1.00mL (100 units on a U-100 syringe)
Recently, glucagon-like peptide 1 (GLP-1) agonists have garnered interest for IIH management due to their weight reduction and potential cerebrospinal fluid production-decreasing effects
In receptor pharmacology research, tesamorelin acts as a selective full agonist at the pituitary GHRHR, a class B G-protein-coupled receptor
The compound dosage chart helps navigate the concentration and dosing specifics that vary between compounding pharmacies